# To Evaluate if Dexmedetomidine Infusion Provides Renal Protection in Patients Undergoing Coronary Artery Bypass Graft

> **NCT05375188** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute of Cardiovascular Diseases, Pakistan** · enrollment: 60 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT05375188
- **Lead sponsor:** National Institute of Cardiovascular Diseases, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05375188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05375188, "To Evaluate if Dexmedetomidine Infusion Provides Renal Protection in Patients Undergoing Coronary Artery Bypass Graft". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05375188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*